Myriad Genetics Adds Folate Receptor Alpha to Precise™

Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE® SALT LAKE CITY, May 24, 2023 -- Myriad Genetics, Inc. , a leader in genetic testing... | June 11, 2023

Related Keywords

San Diego , California , United States , Michael Lyons , Ramezn Eskander , Glenn Farrell , Matt Scalo , Oncology Solutions , Immunogen Inc , Reproductive Sciences , Precise Oncology Solutions , Genetics Inc , Nasdaq , Exchange Commission , National Comprehensive Cancer Network , Uc San Diego School Of Medicine , Department Of Obstetrics , Folate Receptor Alpha , Diego School , Myriad Genetics , Prescribing Information , Boxed Warning , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,